Amesite
AMST
13 hedge funds and large institutions have $394K invested in Amesite in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
8% more funds holding
Funds holding: 12 → 13 (+1)
0.01% more ownership
Funds ownership: 0.27% → 0.28% (+0.01%)
15% less capital invested
Capital invested by funds: $464K → $394K (-$70K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$18.6K |
| 2 |
SG
StoneX Group
New York
|
+$8.72K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$7.64K |
| 4 |
Millennium Management
New York
|
+$6.99K |
| 5 |
Renaissance Technologies
New York
|
+$4.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$22K |
| 2 |
HF
HRT Financial
New York
|
-$9K |
AMST Hedge Fund Activity: Q2 2022 in Review
13 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Amesite (AMST) for Q2 2022, worth a combined $394K — down 15% from $464K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new AMST positions and 3 closed out — a net gain of 1 holder — while 5 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $18.6K. The largest seller was BlackRock, exiting entirely with an estimated $22K sold.
- 13 institutional investors held Amesite (AMST) as of Q2 2022, up from 12 in Q1 2022.
- Funds reported $394K of Amesite stock for Q2 2022, down 15% quarter-over-quarter.
- 4 funds opened new Amesite positions in Q2 2022 and 3 closed out, a net change of +1 holder.
- The largest Amesite buyer in Q2 2022 was Citadel Advisors, an estimated $18.6K added.
- The largest Amesite seller in Q2 2022 was BlackRock, an estimated $22K sold.
Based on aggregated 13F filings for Q2 2022.